---
schema_version: "secwatch.filing_event.v1"
accession: "0000784199-22-000184"
form_type: "8-K"
ticker: "AORT"
cik: "0000784199"
company_name: "ARTIVION, INC."
filed_at: "2022-11-03T23:59:59+00:00"
generated_at: "2026-06-22T10:30:54.832111+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Artivion Q3 revenue $76.8M (+6% GAAP, +11% constant currency); net loss $0.34/share

## Summary
- Revenue $76.8M, up 6% GAAP and 11% constant currency vs Q3 2021.
- On-X revenues up 17% GAAP and 19% constant currency; tissue processing up 13% constant currency.
- Net loss ($13.7M) or ($0.34)/share vs net income $10.6M ($0.26) in Q3 2021. Includes $4.7M PROACT Xa termination charge and $3.7M FX loss.
- Non-GAAP net loss ($1.9M) or ($0.05)/share vs ($1.2M) ($0.03) prior year.
- 2022 outlook: narrowing constant currency revenue growth to 9-10%; full-year revenue expected $313M-$316M.

## SEC filing metadata
- accession: 0000784199-22-000184
- form_type: 8-K
- ticker: AORT
- cik: 0000784199
- company_name: ARTIVION, INC.
- filed_at: 2022-11-03T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/784199/000078419922000184/0000784199-22-000184-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/784199/000078419922000184/aort-20221103.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000784199-22-000184
- JSON: https://secwatch.observer/filing/0000784199-22-000184.json
- Plain text: https://secwatch.observer/filing/0000784199-22-000184.txt

## Key facts
- Earnings Releases
  ARTIVION, INC. reported third quarter ended September 30, 2022 results: revenue $76.8 million, net income ($13.7) million, or ($0.34) per fully diluted common share, EPS ($0.34) per fully diluted common share. Guidance reaffirmed.
  - Period: third quarter ended September 30, 2022
  - Revenue: $76.8 million
  - Net income: ($13.7) million, or ($0.34) per fully diluted common share
  - EPS: ($0.34) per fully diluted common share
  - Guidance: reaffirmed
  - Result: reported results
  source text: Total revenues for the third quarter of 2022 were $76.8 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/784199/000078419922000184/0000784199-22-000184-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.